🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Paul R. Burchard

University of Rochester Medicine

ORCID: 0000-0001-7370-5608

Also affiliated with Golisano Children's Hospital, University of Rochester

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Surgery in combination with systemic chemotherapy is associated with improved survival in stage IV gallbladder cancer”.

Surgery in combination with systemic chemotherapy is associated with improved survival in stage IV gallbladder cancer

European Journal of Surgical Oncology(2022)10.1016/j.ejso.2022.06.029

N/A

0DataRank · unranked

9 citations

Vasileios Tsagkalidis, Paul R. Burchard, Alexander Chacon, Alexa D. Melucci, Alexandra Reitz +6 more

Defining the role of systemic therapy in resectable pancreatic acinar cell carcinoma

Journal of Surgical Oncology(2022)10.1002/jso.26785

N/A

0DataRank · unranked

5 citations

Alexander Chacon, Alexa D. Melucci, Anthony Casabianca, Subir Goyal, Jeffrey M. Switchenko +5 more

A phase I study to evaluate the safety and tolerability of SX-682 in combination with PD-1 inhibitor as maintenance therapy for unresectable pancreatic adenocarcinoma.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.4_suppl.tps631

N/A

0DataRank · unranked

10 citations

Nicholas A. Ullman, Brian A. Belt, Luis I. Ruffolo, Paul R. Burchard, Aram F. Hezel +7 more